HHS

HHS Considers Removing J&J’s Stelara from Medicare Drug Price Negotiations
HHS Considers Removing J&J’s Stelara from Medicare Drug Price Negotiations
BioSpace
JNJ
Stelara
HHS
Inflation Reduction Act
Medicare
drug pricing
Flag link:
HHS Challenges AstraZeneca’s Motion for Summary Judgement in IRA Lawsuit
HHS Challenges AstraZeneca’s Motion for Summary Judgement in IRA Lawsuit
BioSpace
AstraZeneca
legal
HHS
Inflation Reduction Act
Flag link:
HHS pledges to keep Paxlovid available as it transitions to commercial market
HHS pledges to keep Paxlovid available as it transitions to commercial market
The Hill
Pfizer
Paxlovid
antivirals
COVID-19
HHS
Flag link:
Oncology Practices May Be Hurt by Medicare Drug Price Negotiations
Oncology Practices May Be Hurt by Medicare Drug Price Negotiations
OBR Oncology
HHS
Medicare
oncologists
drug pricing
Flag link:
HHS argues Merck 'lacks standing' to sue over Medicare price negotiations
HHS argues Merck 'lacks standing' to sue over Medicare price negotiations
Fierce Pharma
Merck
Inflation Reduction Act
HHS
legal
Flag link:
Biden administration lists 10 drugs for Medicare price negotiation
Biden administration lists 10 drugs for Medicare price negotiation
Medical Marketing and Media
Medicare
HHS
Pfizer
Bristol Myers Squibb
Eli Lilly
Boehringer Ingelheim
AstraZeneca
AbbVie
Novo Nordisk
JNJ
drug pricing
Flag link:
Regeneron, J&J Win HHS Funding to Develop Next-Gen COVID Products
Regeneron, J&J Win HHS Funding to Develop Next-Gen COVID Products
BioSpace
HHS
Regeneron
JNJ
COVID-19
funding
Flag link:
AARP urges courts to keep drug pricing talks on track
AARP urges courts to keep drug pricing talks on track
Yahoo Finance
AARP
legal
HHS
drug pricing
Medicare
CMS
amicus brief
Flag link:
HHS to Back Emergent BioSolutions’ Ebola Drug Development With Potential $704M Award
HHS to Back Emergent BioSolutions’ Ebola Drug Development With Potential $704M Award
GovConWire
Emergent BioSolutions
HHS
ebola virus
Flag link:
U.S. orders antiviral drugs worth $138 million from SIGA Tech
U.S. orders antiviral drugs worth $138 million from SIGA Tech
Reuters
SIGA technologies
TPOXX
HHS
antivirals
Flag link:
US govt addressing Medicare payments for biosimilars
US govt addressing Medicare payments for biosimilars
Pharma Letter
HHS
Medicare
biosimilars
Medicare Part B
Inflation Reduction Act
CMS
Flag link:
HHS to pay for 60K doses of Eli Lilly's COVID-19 drug following its commercialization
HHS to pay for 60K doses of Eli Lilly's COVID-19 drug following its commercialization
Beckers Hospital Review
Eli Lilly
COVID-19
bebtelovimab
federal contracts
HHS
Flag link:
Patient groups sue feds to crack down on insurer, PBM copay adjustment programs
Patient groups sue feds to crack down on insurer, PBM copay adjustment programs
Fierce Healthcare
PBMs
copay asssistance programs
drug pricing
HHS
Flag link:
HHS to distribute 1.6M monkeypox vaccine doses this year
HHS to distribute 1.6M monkeypox vaccine doses this year
Endpoints
monkeypox
HHS
vaccines
Bavarian Nordic
Flag link:
Medicare premiums to remain unchanged after Aduhelm price cut spurs review
Medicare premiums to remain unchanged after Aduhelm price cut spurs review
BioPharma Dive
Medicare
Medicare Part B
Biogen
Aduhelm
HHS
Alzheimer's disease
Flag link:
US sees spike in Paxlovid usage as Merck's molnupiravir and AstraZeneca's Evusheld are slower off the shelf
US sees spike in Paxlovid usage as Merck's molnupiravir and AstraZeneca's Evusheld are slower off the shelf
Endpoints
Pfizer
HHS
Paxlovid
Merck
molnupiravir
AstraZeneca
Evusheld
COVID-19
Flag link:
'March-in' battles heat up as nonprofits petition HHS on 6 drugs as earlier petition awaits decision
'March-in' battles heat up as nonprofits petition HHS on 6 drugs as earlier petition awaits decision
Endpoints
HHS
Bayh-Dole Act
drug pricing
Pfizer
Gilead Sciences
Xtandi
Paxlovid
Epclusa
Descovy
insulin
Flag link:
AstraZeneca pledges more Evusheld doses to US, bringing its antibody supply deal to $855M
AstraZeneca pledges more Evusheld doses to US, bringing its antibody supply deal to $855M
Fierce Pharma
AstraZeneca
COVID-19
Evushield
HHS
Flag link:
Doctor groups urge Biden administration to disclose costs of federally funded clinical trials
Doctor groups urge Biden administration to disclose costs of federally funded clinical trials
Fierce Biotech
Joe Biden
physicians
clinical trials
BARDA
FDA
HHS
Flag link:
FDA Is Back in the Driver’s Seat with LDTs
FDA Is Back in the Driver’s Seat with LDTs
Medical Devices and Diagnostics Industry
FDA
HHS
COVID-19
diagnostics
LDTs
Flag link:

Pages